NS
NVCT icon

NBC Securities’s Nuvectis Pharma NVCT Stock Holding History

NBC Securities’s Portfolio NVCT Stock Details NVCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$110K Buy
6,000
+3,000
+100% +$33.6K 0.01% 1041
2026
Q1 		$23.2K Hold
3,000
– – ﹤0.01% 1655
2025
Q4 		$22.6K Buy
+3,000
New +$19.6K ﹤0.01% 1723
2025
Q1 		– Sell
-5
Closed -$27 – 2135
2024
Q4 		$27 Sell
5
-295
-98% -$1.85K ﹤0.01% 1121
2024
Q3 		$1K Hold
300
– – ﹤0.01% 2087
2024
Q2 		$1K Buy
300
+200
+200% +$1.36K ﹤0.01% 2056
2024
Q1 		$1K Buy
+100
New +$850 ﹤0.01% 2110

Other funds holding NVCT

BWP
Baldwin Wealth Partners Marion, Massachusetts $1.53B AUM 28.5% 1-Year Est. Return
JMFC
J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return
AWM
Austin Wealth Management Austin, Texas $473M AUM 18.73% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
SIC
SJS Investment Consulting Sylvania, Ohio $919M AUM 23.4% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return

NBC Securities's NVCT Position: Q2 2026 in Review

NBC Securities increased its Nuvectis Pharma (NVCT) stake by 100% in Q2 2026, buying an estimated $33.6K and bringing the position to 6,000 shares worth $110K. The position accounts for 0.01% of the portfolio, ranked #1041.

NBC Securities first reported a position in NVCT in Q1 2024 and has held it in 7 quarters since. 9 funds tracked by Wall St. Rank hold NVCT as of Q2 2026.

  • NBC Securities held 6,000 shares of Nuvectis Pharma worth $110K as of Q2 2026.
  • NBC Securities bought 3,000 Nuvectis Pharma shares in Q2 2026, an estimated $33.6K.
  • Nuvectis Pharma made up 0.01% of NBC Securities's portfolio in Q2 2026, its #1041 holding.
  • NBC Securities first reported a position in Nuvectis Pharma in Q1 2024 and has held it in 7 quarters since.
  • 9 funds tracked by Wall St. Rank held Nuvectis Pharma as of Q2 2026.

Based on NBC Securities's 13F filing for Q2 2026, filed 21 Jul 2026.